Dr. Mehrdad Abedi

 

Dr. Mehrdad Abedi, MD, is a highly accomplished hematologist-oncologist specializing in hematologic malignancies, stem cell transplantation, and cellular therapy. He serves as Professor of Medicine at the UC Davis Comprehensive Cancer Center, where he is a key member of the Division of Malignant Hematology, Cellular Therapy, and Transplantation. Dr. Abedi earned his medical degree from Tehran University of Medical Sciences and completed his residency in internal medicine at Yale-affiliated Bridgeport Hospital. He went on to complete fellowship training in hematology and oncology at the University of Massachusetts and Roger Williams Medical Center. He is board-certified in Internal Medicine, Hematology, and Medical Oncology and is widely regarded for his expertise in treating complex blood cancers and advancing transplant-based therapies.

A leader in clinical and translational research, Dr. Abedi has focused his work on improving outcomes for patients with relapsed or refractory leukemias and lymphomas. His research includes developing novel strategies to enhance stem cell transplantation, reduce graft-versus-host disease, and explore cellular immunotherapies. He is actively involved in clinical trials that investigate next-generation treatments for high-risk hematologic cancers and has contributed to the integration of personalized medicine in the field. His work has been published in peer-reviewed journals, and he regularly collaborates across disciplines to bring innovative therapies from bench to bedside.

In addition to his clinical and research responsibilities, Dr. Abedi is a dedicated educator and mentor to fellows, residents, and medical students. He is known for his compassionate approach to care and his ability to communicate complex treatment plans with clarity and empathy. He works closely with multidisciplinary teams to deliver comprehensive and individualized treatment for patients undergoing stem cell transplantation and other advanced therapies. Through his commitment to innovation, education, and patient-centered care, Dr. Mehrdad Abedi continues to make significant contributions to the field of hematologic oncology and cellular therapy.